Regulatory glossary

FDA Form 483 Response: What to Write and When

Form FDA 483, Inspectional Observations, is the list an FDA investigator leaves at the close of an inspection. It records conditions the investigator judged to be objectionable under the Federal Food, Drug, and Cosmetic Act.

Two things it is not. It is not a final agency determination, and it is not a citation of the regulation you broke. It is one investigator's observations, written for your management to act on.

That distinction matters when you write back. A 483 is the last point at which the record is still yours to shape.

The 15 business day window

FDA reviews a response received within 15 business days of the 483 being issued before it decides whether to issue a Warning Letter. Respond later and the agency will ordinarily proceed without waiting for you.

The window is short by design and it is business days, not calendar days. Count from the date the 483 was issued, not the date it reached your quality unit.

You are not expected to have finished the work in fifteen days. You are expected to have committed to it, in writing, with dates.

What the response has to do per observation

Take each observation separately and answer four questions.

• The immediate correction. What you did about the specific instance the investigator saw. Product quarantined, batch rejected, procedure suspended.
• Root cause. Why it happened. An observation answered with a correction and no cause reads as a company that has not looked.
• The systemic action. Where else the same cause could produce the same failure, and what you are changing there. This is the part that decides whether the observation recurs at the next inspection.
• Evidence and dates. Attach what exists. For what does not exist yet, give a target date for a named milestone.

Avoid "in Q3". Give a date. A quarter reads as an estimate; a date reads as a plan someone has resourced.

Where a response goes wrong

Arguing the observation. You may disagree, and there is a way to say so, but a response whose first move is to dispute the investigator's judgement rarely ends the matter.

Correcting the instance only. The investigator saw one batch record. The question FDA is really asking is what your batch records look like generally.

Promising a CAPA with no owner. Commitments are read back to you at the next inspection. Investigators commonly return within 6 to 18 months and ask for evidence that what you committed to was completed on the date you gave.

Silence on the hard one. An unanswered observation is the one that gets quoted in the Warning Letter.

What happens next

The investigator files an Establishment Inspection Report and the district classifies the inspection:

• NAI, no action indicated.
• VAI, voluntary action indicated. Objectionable conditions, but not at a level warranting formal action.
• OAI, official action indicated. This is the classification that precedes a Warning Letter, an import alert, or in the worst case a consent decree.

Your response is read as part of that classification. It is the cheapest opportunity you will get to move the outcome.